Jump to content

Property:Cancer stage specification

From CAMIH

This is a property of type Text.

Showing 20 pages using this property.
S
People with metastases outside the abdominal area were excluded. Karnovsky Index >50% Abdominal cancer types in enzyme arm; in control arm: Ovarian carcinoma: 2; 2 Uterine carcinoma: 11; 15 Prostate carcinoma: 14; 2 Intestinal carcinoma: 3; 7 Hypernephroma (with pelvic metastases): 1; 1 Carcinoma of the vas deferens: 1; - Head and neck carcinoma: 1; - Bladder carcinoma: 1; - Non-Hodgkin's lymphoma: -; 1 Chronic lymphocytic leukemia: -; 1 Vaginal carcinoma: 1; 2 Rectal carcinoma: - ; 1 Double carcinoma: 1; -  +
Histologically confirmed Stage II-IVM0 carcinoma of the head and neck Primary tumor site (n): Oral cavity: Aloe = 1 (4%); Placebo = 8 (27%) Oropharynx: Aloe = 9 (32%); Placebo = 2 (7%) Larynx: Aloe = 6 (21%); Placebo =7 (23%) Hypopharynx: Aloe = 2 (7%); Placebo = 1 (3%) Nasopharynx: Aloe = 4 (14%); Placebo = 6 (20%) Unknown primary: Aloe = 4 (14%); Placebo = 1 (3%) Other: Aloe = 2 (7%); Placebo = 5 (17%)  +
T
Hematological tumor classification in enyzme arm; control arm: Acute lymphoblastic leukemia: 13 (36.11%); 12 (33.33%) Acute non-lymphocytic leukemia: 11 (30.56%); 9 (25.00%) Aplastic anemia: 5 (13.89%); 6 (16.67%) Non-Hodgkin's lymphoma: 4 (11.11%); 5 (13.89%) Langerhans cell histocytosis: 3 (8.33%); 4 (11.11%)  +
N (%) per arm: - intervention: 77 (74) stage I, 27 (26) stage II - control: 72 (65.5) stage I, 38 (34.5) stage II  +
U
Cancer stage, n (%) Stage 1: 13 (27.7), stage 2: 2 (4.3), stage 3: 16 (34.0), stage 4: 3 (6.4), recurrent: 13 (27.7)  +
V
Per arm, n stage I/n stage II/n stage III: - vit. A: 395/167/85 - NAC: 371/176/95 - vit. A + NAC: 376/182/85 - control: 382/184/77  +